Cargando…

Immune responses to SARS-CoV-2 infection in Humans and ACE2 humanized mice

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a major public health threat worldwide. Insight into protective and pathogenic aspects of SARS-CoV-2 immune responses is critical to work out effective therapeutics and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Airu, Chen, Zhao, Wang, Yanqun, Zeng, Qiuhui, Sun, Jing, Zhuang, Zhen, Li, Fang, Zhao, Jingxian, Zhao, Jincun, Zhong, Nanshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Publishing Services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927650/ http://dx.doi.org/10.1016/j.fmre.2021.03.001

Ejemplares similares

Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo
por: Zhang, Zhaoyong, et al.
Publicado: (2021)

Narrative review of the novel coronavirus SARS-CoV-2: update on genomic characteristics, transmissions and animal model
por: Zhang, Zhaoyong, et al.
Publicado: (2020)

Mapping and role of T cell response in SARS-CoV-2–infected mice
por: Zhuang, Zhen, et al.
Publicado: (2021)

Correction: Mapping and role of T cell response in SARS-CoV-2–infected mice
por: Zhuang, Zhen, et al.
Publicado: (2021)

Sensitization of Non-permissive Laboratory Mice to SARS-CoV-2 with a Replication-Deficient Adenovirus Expressing Human ACE2
por: Wong, Lok-Yin Roy, et al.
Publicado: (2020)

Population Bottlenecks and Intra-host Evolution During Human-to-Human Transmission of SARS-CoV-2
por: Wang, Daxi, et al.
Publicado: (2021)

Broadly Effective ACE2 Decoy Proteins Protect Mice from Lethal SARS-CoV-2 Infection
por: Lu, Mengjia, et al.
Publicado: (2023)

Successful clearance of persistent SARS-CoV-2 asymptomatic infection following a single dose of Ad5-nCoV vaccine
por: Qiu, Shaofu, et al.
Publicado: (2023)

Antigenic characterization of SARS-CoV-2 Omicron subvariants XBB.1.5, BQ.1, BQ.1.1, BF.7 and BA.2.75.2
por: Zhu, Airu, et al.
Publicado: (2023)

Evasion by Stealth: Inefficient Immune Activation Underlies Poor T Cell Response and Severe Disease in SARS-CoV-Infected Mice
por: Zhao, Jincun, et al.
Publicado: (2009)

Complete Genome Sequences of Five Human Coronavirus NL63 Strains Causing Respiratory Illness in Hospitalized Children in China
por: Zhang, Lu, et al.
Publicado: (2020)

Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient
por: Sun, Jing, et al.
Publicado: (2020)

P21-activated kinase 1 (PAK1)-mediated cytoskeleton rearrangement promotes SARS-CoV-2 entry and ACE2 autophagic degradation
por: Liu, Ming, et al.
Publicado: (2023)

Intra-host variation and evolutionary dynamics of SARS-CoV-2 populations in COVID-19 patients
por: Wang, Yanqun, et al.
Publicado: (2021)

Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy
por: Jin, Shouheng, et al.
Publicado: (2022)

Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19
por: Xiao, Fei, et al.
Publicado: (2020)

The N-Terminal Region of Middle East Respiratory Syndrome Coronavirus Accessory Protein 8b Is Essential for Enhanced Virulence of an Attenuated Murine Coronavirus
por: Li, Yuming, et al.
Publicado: (2022)

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
por: Ge, Jiwan, et al.
Publicado: (2021)

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
por: Zhang, Haibo, et al.
Publicado: (2020)

Particulate matter exposure exacerbates susceptibility to SARS-CoV-2 infection in humanized ACE2 mice
por: Zhu, Teng-Yu, et al.
Publicado: (2021)

Binding of SARS-COV-2 (COVID-19) and SARS-COV to human ACE2: Identifying binding sites and consequences on ACE2 stiffness
por: Faisal, H.M. Nasrullah, et al.
Publicado: (2021)

Human Intestinal Defensin 5 Inhibits SARS-CoV-2 Invasion by Cloaking ACE2
por: Wang, Cheng, et al.
Publicado: (2020)

Differential Pathogenesis of SARS-CoV-2 Variants of Concern in Human ACE2-Expressing Mice
por: Natekar, Janhavi Prasad, et al.
Publicado: (2022)

Immune responses to human respiratory coronaviruses infection in mouse models
por: Zhuang, Zhen, et al.
Publicado: (2022)

Structural characteristics of the SARS-CoV-2 Omicron lineages BA.1 and BA.2 virions
por: Ma, Xiaoyu, et al.
Publicado: (2023)

Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018
por: Wang, Yanqun, et al.
Publicado: (2020)

Differential Effects of IL-12 on Tregs and Non-Treg T Cells: Roles of IFN-γ, IL-2 and IL-2R
por: Zhao, Jingxian, et al.
Publicado: (2012)

Human post‐infection serological response to the spike and nucleocapsid proteins of SARS‐CoV‐2
por: Xiao, Cheng, et al.
Publicado: (2020)

Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 infection
por: Yeung, Stephen T., et al.
Publicado: (2022)

Mice Humanized for MHC and hACE2 with High Permissiveness to SARS-CoV-2 Omicron Replication
por: Le Chevalier, Fabien, et al.
Publicado: (2023)

Repurposing CRISPR/Cas to Discover SARS‐CoV‐2 Detecting and Neutralizing Aptamers
por: Zhang, Ju, et al.
Publicado: (2023)

SARS-CoV-2 induces cardiomyocyte apoptosis and inflammation but can be ameliorated by ACE inhibitor Captopril
por: Huang, Xiaohan, et al.
Publicado: (2023)

Comparative pathology of the nasal epithelium in K18-hACE2 Tg mice, hACE2 Tg mice, and hamsters infected with SARS-CoV-2
por: Yu, Pin, et al.
Publicado: (2022)

Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2
por: Liu, Donglan, et al.
Publicado: (2023)

Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor
por: Zhao, Peng, et al.
Publicado: (2020)

Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor
por: Zhao, Peng, et al.
Publicado: (2020)

Detection of Anti-SARS-CoV-2-S2 IgG Is More Sensitive Than Anti-RBD IgG in Identifying Asymptomatic COVID-19 Patients
por: Liao, Baolin, et al.
Publicado: (2021)

Cold-Adapted Live Attenuated SARS-Cov-2 Vaccine Completely Protects Human ACE2 Transgenic Mice from SARS-Cov-2 Infection
por: Seo, Sang Heui, et al.
Publicado: (2020)

Inactivated SARS-CoV-2 induces acute respiratory distress syndrome in human ACE2-transgenic mice
por: Bi, Zhenfei, et al.
Publicado: (2021)

SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice
por: Winkler, Emma S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ohoivvn77b49dcv123pnjrrv80